RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Reperfusion Injury |
|
Accession: | DOID:9004009
|
browse the term
|
Definition: | Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY. |
Synonyms: | exact_synonym: | Ischemia Reperfusion Injury; Ischemia-Reperfusion Injuries; Reperfusion Damage; Reperfusion Damages; Reperfusion Injuries |
| primary_id: | MESH:D015427; RDO:0006865 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
|
IEP |
mRNA, protein:increased expression:brain, neuron |
RGD |
PMID:16997484 |
RGD:2301088 |
NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
|
IEP |
mRNA, protein:increased expression, altered localization:small intestine |
RGD |
PMID:18451542 |
RGD:2315580 |
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IMP |
|
RGD |
PMID:20436217 |
RGD:2325213 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
IEP |
mRNA:increased expression:hippocampal granule cell |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 9:121,705,897...121,725,736
Ensembl chr 9:121,706,979...121,725,716
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
IEP |
mRNA:decreased expression:dentate gyrus (rat) |
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 4:85,662,809...85,711,696
Ensembl chr 4:85,662,892...85,711,696
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
|
IEP |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr19:25,029,037...25,069,146
Ensembl chr19:25,029,037...25,069,142
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
|
IEP |
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr14:28,362,176...29,226,085
Ensembl chr14:28,393,394...28,967,980
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
IMP |
associated with Non-alcoholic Fatty Liver Disease; |
RGD |
PMID:18098300 |
RGD:5686804 |
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adm |
adrenomedullin |
|
IEP |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
|
|
G |
Adora2a |
adenosine A2a receptor |
|
IDA ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27757725, PMID:17937935 |
RGD:4890367 |
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
|
|
G |
Adora2b |
adenosine A2B receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27757725 |
|
NCBI chr10:48,569,563...48,586,366
Ensembl chr10:48,569,555...48,586,365
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
IMP |
|
RGD |
PMID:20451506 |
RGD:5129116 |
NCBI chr 1:277,537,585...277,538,985
Ensembl chr 1:277,537,585...277,538,985
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
IDA |
|
RGD |
PMID:14630341, PMID:18336819 |
RGD:1598754, RGD:4145097 |
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
IDA |
|
RGD |
PMID:22920387 |
RGD:6903870 |
NCBI chr X:119,389,480...119,393,845
Ensembl chr X:119,390,013...119,393,842
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:increased expression:Kupffer cell (rat) |
RGD |
PMID:16500929 |
RGD:2313040 |
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
|
RGD |
PMID:21351045 |
RGD:5509067 |
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16397181 |
|
NCBI chr 1:100,845,443...100,851,961
Ensembl chr 1:100,845,563...100,851,960
|
|
G |
Alb |
albumin |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:20193666 |
RGD:2325686 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
|
IEP |
|
RGD |
PMID:10395295 |
RGD:1599061 |
NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
IEP |
|
RGD |
PMID:15518705 |
RGD:5509617 |
NCBI chr10:56,851,734...56,864,049
Ensembl chr10:56,851,734...56,864,005
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:18635843 |
RGD:5509608 |
NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IEP ISO IMP |
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15266012, PMID:14769366, PMID:19816089 |
RGD:1626152, RGD:2317531 |
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Ang |
angiogenin |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19666176 |
RGD:2325717 |
NCBI chr15:28,022,926...28,028,636
|
|
G |
Angpt1 |
angiopoietin 1 |
|
ISO |
|
RGD |
PMID:19885826 |
RGD:2316041 |
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
|
IMP |
|
RGD |
PMID:16339390 |
RGD:2313821 |
NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
IEP |
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
IEP |
protein:increased expression:placenta |
RGD |
PMID:18373555 |
RGD:2315671 |
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
Aqp4 |
aquaporin 4 |
|
IEP ISO |
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex |
RGD |
PMID:20979759, PMID:21718723, PMID:19806476, PMID:20924629 |
RGD:5148016, RGD:5684013, RGD:5148037, RGD:5148022 |
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
Arg1 |
arginase 1 |
|
IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:17023552 |
RGD:4143185 |
NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
|
|
G |
Asl |
argininosuccinate lyase |
resistance |
IEP |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr12:30,160,922...30,178,348
Ensembl chr12:30,165,694...30,178,341
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
resistance |
IEP |
protein:increased expression:brain, neuron (rat) |
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
protein:altered localization:brain, mitochondria |
RGD |
PMID:18347331 |
RGD:2292679 |
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bag1 |
BAG cochaperone 1 |
|
IMP |
|
RGD |
PMID:12215270 |
RGD:2296021 |
NCBI chr 5:57,254,421...57,267,002
Ensembl chr 5:57,254,421...57,267,002
|
|
G |
Bag3 |
BAG cochaperone 3 |
|
IEP |
protein:increased expression:hippocampus, astrocyte |
RGD |
PMID:12061864 |
RGD:2325848 |
NCBI chr 1:199,941,258...199,965,191
Ensembl chr 1:199,941,161...199,965,191
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:18083315, PMID:18221257 |
RGD:2290557, RGD:2293026 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15449323 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
mRNA:increased expression:retina |
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Becn1 |
beclin 1 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:22306244 |
RGD:6483054 |
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
IDA |
|
RGD |
PMID:19888517 |
RGD:2317562 |
NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP IMP |
protein:increased expression:brain |
RGD |
PMID:18159002, PMID:18053646 |
RGD:2293126, RGD:2293127 |
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
IEP |
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chr17:26,955,142...27,112,820
Ensembl chr17:26,955,142...27,112,820
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
IEP |
mRNA:increased expression:dentate gyrus, granule cell |
RGD |
PMID:10996456 |
RGD:5129486 |
NCBI chr 9:66,568,074...66,683,019
Ensembl chr 9:66,568,074...66,676,494
|
|
G |
Bsg |
basigin (Ok blood group) |
|
IEP |
protein:increased expression:basal ganglia |
RGD |
PMID:16029217 |
RGD:2289063 |
NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:9712737 |
RGD:2289078 |
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
C3 |
complement C3 |
|
IEP |
protein:increased expression:intestine |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C3ar1 |
complement C3a receptor 1 |
|
IMP |
|
RGD |
PMID:15159277 |
RGD:5129702 |
NCBI chr 4:155,681,767...155,691,240
Ensembl chr 4:155,684,029...155,690,869
|
|
G |
C5 |
complement C5 |
|
IDA |
|
RGD |
PMID:15158333 |
RGD:1600597 |
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
|
|
G |
C5ar1 |
complement C5a receptor 1 |
|
IMP |
|
RGD |
PMID:15158333, PMID:15159277 |
RGD:1600597, RGD:5129702 |
NCBI chr 1:78,186,777...78,195,132
Ensembl chr 1:78,186,776...78,195,328
|
|
G |
Casp1 |
caspase 1 |
|
IMP |
|
RGD |
PMID:17845807 |
RGD:2315890 |
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
|
|
G |
Casp12 |
caspase 12 |
|
IEP |
|
RGD |
PMID:18273070 |
RGD:2311461 |
NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
|
|
G |
Casp3 |
caspase 3 |
treatment |
IMP IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703, PMID:18490106, PMID:29568770 |
RGD:2293311, RGD:13792595 |
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp6 |
caspase 6 |
|
IEP |
protein:increased expression, increased activity:small intestine mucosa |
RGD |
PMID:15010362 |
RGD:2301320 |
NCBI chr 2:235,341,326...235,353,715
Ensembl chr 2:235,341,365...235,353,967 Ensembl chr 2:235,341,365...235,353,967
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
treatment |
IDA |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:11035539 |
RGD:5509823 |
NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
|
|
G |
Cat |
catalase |
|
IDA ISO IEP |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:8215636 PMID:16682413 PMID:23743330 PMID:23875703, PMID:19196076, PMID:20888583 |
RGD:5130760, RGD:5130200 |
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cav1 |
caveolin 1 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17293479 |
RGD:2289123 |
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP |
mRNA:increased expression:aorta |
RGD |
PMID:9665468 |
RGD:4145482 |
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IDA ISO |
Gastric Reperfusion Injury CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12468449 PMID:15829914, PMID:22611311 |
RGD:8549744 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15829914 |
|
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO IEP |
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut |
RGD |
PMID:19558673, PMID:15542513 |
RGD:4891479, RGD:2307184 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccnb1 |
cyclin B1 |
|
IEP |
protein;altered expression:cerebral cortex, hippocampus CA1, neuron |
RGD |
PMID:18278459 |
RGD:2315990 |
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
|
|
G |
Ccnd1 |
cyclin D1 |
|
IEP |
|
RGD |
PMID:16718823 |
RGD:2289145 |
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccne1 |
cyclin E1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:17584601 |
RGD:2289275 |
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Ccng1 |
cyclin G1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:9698156 |
RGD:2316027 |
NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:20410256 |
RGD:5688141 |
NCBI chr 8:132,996,646...133,002,201
Ensembl chr 8:132,996,649...133,002,201
|
|
G |
Cd2ap |
CD2-associated protein |
|
IEP |
|
RGD |
PMID:16088078 |
RGD:1581187 |
NCBI chr 9:20,794,680...20,858,438
Ensembl chr 9:20,765,296...20,858,504
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd40 |
CD40 molecule |
|
IMP |
|
RGD |
PMID:12388354 |
RGD:5508171 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO IMP |
|
RGD |
PMID:20659085, PMID:12388354 |
RGD:5490531, RGD:5508171 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
IEP |
protein:increased expression:kidney protein:increased expression:testis, macrophage |
RGD |
PMID:16786159, PMID:16891795 |
RGD:2289354, RGD:2289369 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
|
IEP |
|
RGD |
PMID:20403613 |
RGD:2326175 |
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
|
|
G |
Cd59 |
CD59 molecule |
|
IDA |
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
|
|
G |
Cdc42 |
cell division cycle 42 |
|
IDA |
protein:increased activation:hippocampus CA1 |
RGD |
PMID:17161586 |
RGD:2298583 |
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16968891, PMID:10451498 |
RGD:10043817 |
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:increased expression:skeletal muscle |
RGD |
PMID:15799773 |
RGD:2293627 |
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cfh |
complement factor H |
|
IEP |
protein:increased expression:plasma: |
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr16:8,576,858...8,686,131
Ensembl chr16:8,577,840...8,686,131
|
|
G |
Cldn4 |
claudin 4 |
|
IEP |
protein:increased expression, altered localization:small intestine epithelium |
RGD |
PMID:17375208 |
RGD:2317600 |
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
IMP |
|
RGD |
PMID:19372445 |
RGD:2314674 |
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
IEP |
|
RGD |
PMID:17565360 |
RGD:5686869 |
NCBI chr 8:61,532,465...61,567,510
Ensembl chr 8:61,532,465...61,567,510
|
|
G |
Ctsb |
cathepsin B |
|
IEP |
protein:increased expression:cerebral cortex, mitochondrion (rat) |
RGD |
PMID:18938146 |
RGD:2315506 |
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
|
|
G |
Ctsg |
cathepsin G |
|
ISO |
|
RGD |
PMID:17322378 |
RGD:7242055 |
NCBI chr15:35,107,333...35,113,678
Ensembl chr15:35,111,091...35,113,678
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:19563789 |
RGD:4891956 |
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO IEP |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316, PMID:20160675, PMID:10655268 |
RGD:5134970, RGD:5135270 |
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
IEP ISO |
mRNA:increased expression:liver protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:18589091, PMID:16709871, PMID:19433855 |
RGD:2311376, RGD:5135441, RGD:5135307 |
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
IEP |
protein:increased expression:retina |
RGD |
PMID:18709383 |
RGD:2306570 |
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP ISO |
mRNA:increased expression:jejunum, lung CTD Direct Evidence: marker/mechanism protein:increased expression:liver mRNA:increased expression:liver |
CTD |
PMID:12468449, PMID:19691980, PMID:10655268, PMID:11580116, PMID:20160675 |
RGD:5134974, RGD:5135270, RGD:5135251, RGD:5134970 |
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:11580116, PMID:10655268 |
RGD:5135251, RGD:5135270 |
NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
associated with Anemia, Sickle Cell;protein:increased expression:lung |
RGD |
PMID:19433855 |
RGD:5135307 |
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18589091 |
RGD:2311376 |
NCBI chr X:71,614,346...71,616,997
Ensembl chr X:71,614,346...71,616,997
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
|
IEP |
|
RGD |
PMID:15148062 |
RGD:1599683 |
NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876
|
|
G |
Cybb |
cytochrome b-245 beta chain |
|
IEP ISO |
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19193722, PMID:16766636 |
RGD:1599677 |
NCBI chr X:14,578,330...14,610,049
Ensembl chr X:14,578,264...14,612,547
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
IEP |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:21114983 |
RGD:4890041 |
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:21094789 |
RGD:4892235 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22749977 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:18790177 |
RGD:4781446 |
NCBI chr X:77,671,028...77,700,491
Ensembl chr X:77,674,150...77,700,269
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:21664436 |
RGD:5144004 |
NCBI chr15:54,903,290...54,941,742
Ensembl chr15:54,905,274...54,906,203
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17574219 |
RGD:2314372 |
NCBI chr18:66,518,213...67,629,801
Ensembl chr18:66,523,120...67,224,566
|
|
G |
Dsg1 |
desmoglein 1 |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chr18:12,008,301...12,040,337
Ensembl chr18:12,008,759...12,038,053
|
|
G |
Edn1 |
endothelin 1 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17470888, PMID:18722366 |
RGD:4892577 |
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Edn2 |
endothelin 2 |
|
IEP |
|
RGD |
PMID:1479622 |
RGD:1580920 |
NCBI chr 5:139,098,472...139,106,396
Ensembl chr 5:139,100,898...139,105,792
|
|
G |
Ednrb |
endothelin receptor type B |
|
IEP |
|
RGD |
PMID:18722366 |
RGD:4892577 |
NCBI chr15:88,004,775...88,036,354
Ensembl chr15:88,006,977...88,036,354
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
IEP |
protein:hypophosphorylation:cortex, hippocampus: |
RGD |
PMID:15211596 |
RGD:10401223 |
NCBI chr 7:11,401,501...11,406,771
Ensembl chr 7:11,401,501...11,406,771
|
|
G |
Efna5 |
ephrin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 9:110,054,002...110,329,878
Ensembl chr 9:110,057,155...110,225,486
|
|
G |
Efnb2 |
ephrin B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr16:86,631,151...86,672,050
Ensembl chr16:86,631,064...86,675,049
|
|
G |
Egf |
epidermal growth factor |
resistance |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316, PMID:16417467 |
RGD:6906916 |
NCBI chr 2:68,820,616...68,895,537
|
|
G |
Egr1 |
early growth response 1 |
|
ISO IEP |
Lung Reperfusion Injury CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse) |
CTD |
PMID:12468449, PMID:16551742, PMID:16488723, PMID:19342415 |
RGD:5131903, RGD:5131904, RGD:5131887 |
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19041636 |
|
NCBI chr 2:148,722,343...148,755,781
Ensembl chr 2:148,722,231...148,755,520
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
IDA |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
IDA |
protein:increased phosphorylation:kidney |
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
|
|
G |
Eno2 |
enolase 2 |
|
IDA |
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Ep300 |
E1A binding protein p300 |
treatment |
IDA IEP |
retina retina; protein:altered localization:Hsp70, promoter (rat) |
RGD |
PMID:22143029, PMID:22143029 |
RGD:5686888, RGD:5686888 |
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
|
|
G |
Epha2 |
Eph receptor A2 |
|
IDA |
|
RGD |
PMID:16735461 |
RGD:1580976 |
NCBI chr 5:159,845,773...159,874,203
Ensembl chr 5:159,845,774...159,874,206
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:19471280 |
RGD:5688359 |
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
IMP |
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 8:33,756,634...33,879,625
Ensembl chr 8:33,816,386...33,879,625
|
|
G |
F2 |
coagulation factor II |
|
IMP |
|
RGD |
PMID:20705928 |
RGD:5147777 |
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IDA |
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
IDA ISO |
Rat model using human FGF1 |
RGD |
PMID:19497570, PMID:16635575 |
RGD:5509879, RGD:5509881 |
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
IEP ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267, PMID:15121240 |
RGD:2293779 |
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:15121240 |
RGD:2293779 |
NCBI chr 6:25,598,936...25,616,995
Ensembl chr 6:25,598,936...25,616,995
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
IEP |
|
RGD |
PMID:17250641 |
RGD:2307361 |
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 |
|
NCBI chr10:88,245,532...88,248,485
Ensembl chr10:88,245,532...88,248,484
|
|
G |
Gh1 |
growth hormone 1 |
treatment |
ISO |
|
RGD |
PMID:21439711 |
RGD:10003153 |
NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16581065 |
|
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25530438 |
|
NCBI chr X:71,272,030...71,279,973
Ensembl chr X:71,272,042...71,279,977
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
IEP |
protein:decreased activity:brain |
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
IEP |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
|
IEP |
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 2:210,896,779...210,934,733
Ensembl chr 2:210,896,656...210,934,749
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8215636 |
|
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23743330 |
|
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
IEP |
mRNA:decreased expression:hippocampus (rat) |
RGD |
PMID:20408958 |
RGD:4107069 |
NCBI chr10:42,441,723...42,760,200
Ensembl chr10:42,614,713...42,760,200
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
IMP |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr20:53,791,428...54,517,691
Ensembl chr20:53,789,760...54,517,709
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
|
IMP |
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr 1:81,885,516...81,946,731
Ensembl chr 1:81,885,521...81,946,714
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr10:5,707,806...6,123,568
Ensembl chr10:5,930,298...6,119,990
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:24904723 |
RGD:10401882 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:17142801 |
RGD:6903953 |
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7635938 |
|
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
IDA |
Spinal Cord Reperfusion Injury Limb Reperfusion Injury |
RGD |
PMID:16465055, PMID:23816242 |
RGD:9068924, RGD:9068927 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IMP |
|
RGD |
PMID:22392147 |
RGD:10402071 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
IMP ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21724106, PMID:16009498, PMID:18398369 |
RGD:5508445, RGD:5508473, RGD:2315888 |
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IDA ISO IEP IMP |
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid |
CTD |
PMID:12352873 PMID:16982915 PMID:17660127 PMID:17906103 PMID:23075401 PMID:25780291, PMID:16699460, PMID:19885035, PMID:12919086 |
RGD:1582708, RGD:4145338, RGD:4145514 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hrh3 |
histamine receptor H3 |
|
IDA |
|
RGD |
PMID:17169356 |
RGD:1626416 |
NCBI chr 3:175,474,310...175,479,395
Ensembl chr 3:175,473,078...175,479,395
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO IEP |
|
RGD |
PMID:10965299, PMID:10550516 |
RGD:7242748, RGD:7242749 |
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
IMP |
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain |
RGD |
PMID:22075494 |
RGD:5685650 |
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10216529 |
|
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19193722 |
|
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11557319 PMID:23743330 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
|
|
G |
Ifng |
interferon gamma |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:19514843 |
RGD:2308950 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
|
RGD |
PMID:16306169 |
RGD:1598442 |
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Il10 |
interleukin 10 |
|
IEP ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18460982, PMID:19514843, PMID:12388354, PMID:16141682 |
RGD:2308950, RGD:5508171, RGD:1598625 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
|
|
G |
Il13 |
interleukin 13 |
|
IEP ISO |
protein:decreased expression:plasma |
RGD |
PMID:18354382, PMID:18354382 |
RGD:2301685, RGD:2301685 |
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:19394645, PMID:16052682 |
RGD:4889555, RGD:4889825 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23875703 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD |
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:21940958, PMID:20680426, PMID:20659747 |
RGD:4143250, RGD:4143253 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr 2:189,196,180...189,255,987
Ensembl chr 2:189,205,701...189,254,628
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
|
|
G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr 9:94,745,220...94,850,778
Ensembl chr 9:94,745,217...94,850,771
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr 7:64,922,830...64,982,224
Ensembl chr 7:64,923,615...64,982,281
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
|
|
G |
Itga2b |
integrin subunit alpha 2b |
|
IMP |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr10:90,397,960...90,416,550
Ensembl chr10:90,398,132...90,415,070
|
|
G |
Itga5 |
integrin subunit alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 7:144,970,444...144,993,652
Ensembl chr 7:144,970,444...144,993,652
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
IMP |
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:20440769 |
RGD:6483026 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7922267 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
IDA |
|
RGD |
PMID:10708603 |
RGD:1581697 |
NCBI chr 4:176,783,287...176,789,143
Ensembl chr 4:176,782,498...176,789,304
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP ISO |
mRNA:increased expression:hippocampus CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316, PMID:17402857 |
RGD:5684415 |
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO IEP |
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat) |
RGD |
PMID:21075092, PMID:18078953 |
RGD:6893270, RGD:6902919 |
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
|
|
G |
Klk1 |
kallikrein 1 |
|
IEP |
|
RGD |
PMID:12746231 |
RGD:1641806 |
NCBI chr 1:100,131,562...100,135,556
Ensembl chr 1:100,059,967...100,203,329 Ensembl chr 1:100,059,967...100,203,329 Ensembl chr 1:100,059,967...100,203,329
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
IEP |
|
RGD |
PMID:17288738 |
RGD:2324630 |
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
|
|
G |
Lep |
leptin |
|
IDA |
|
RGD |
PMID:21086559 |
RGD:5128549 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lig3 |
DNA ligase 3 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr10:70,134,734...70,158,051
Ensembl chr10:70,134,729...70,158,055
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19773801 |
RGD:2325809 |
NCBI chr 8:115,623,175...115,626,408
Ensembl chr 8:115,623,178...115,626,380
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chr 9:73,204,753...73,462,965
Ensembl chr 9:73,319,710...73,462,972
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20302854, PMID:16699462 |
RGD:1582310 |
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
IDA |
protein:increased activity:hippocampus |
RGD |
PMID:16805806 |
RGD:2293339 |
NCBI chr10:14,259,394...14,299,276
Ensembl chr10:14,260,787...14,299,167
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19667931 PMID:20302854 |
|
NCBI chr10:35,333,859...35,374,364
Ensembl chr10:35,333,859...35,374,355
|
|
G |
Mb |
myoglobin |
|
ISO |
|
RGD |
PMID:12788661 |
RGD:1582427 |
NCBI chr 7:118,101,633...118,108,864
Ensembl chr 7:118,101,634...118,108,864
|
|
G |
Mbl1 |
mannose binding lectin 1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:16982912, PMID:15509537 |
RGD:1582132, RGD:6903263 |
NCBI chr16:18,736,154...18,742,193
Ensembl chr16:18,736,154...18,742,193
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15882434, PMID:15509537 |
RGD:6903262, RGD:6903263 |
NCBI chr 1:248,435,069...248,442,669
Ensembl chr 1:248,723,397...248,729,962
|
|
G |
Mc1r |
melanocortin 1 receptor |
no_association |
ISO |
|
RGD |
PMID:18757499 |
RGD:5687323 |
NCBI chr19:56,215,420...56,219,987
|
|
G |
Mdk |
midkine |
|
ISO |
|
RGD |
PMID:15780085 |
RGD:1582475 |
NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
IEP |
mRNA:increased expression:retina (rat) |
RGD |
PMID:17113948 |
RGD:2317505 |
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
|
|
G |
Mif |
macrophage migration inhibitory factor |
disease_progression |
ISO |
|
RGD |
PMID:18055556 |
RGD:4891010 |
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
|
|
G |
Mir148b |
microRNA 148b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30308185 |
|
NCBI chr 7:144,912,038...144,912,134
Ensembl chr 7:144,912,038...144,912,134
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
IEP |
protein:increased protein, activity:brain |
RGD |
PMID:15099024 |
RGD:2325962 |
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO IMP IEP |
CTD Direct Evidence: marker/mechanism associated with lung injury; mRNA, protein:increased expression:lung |
CTD |
PMID:23075401, PMID:16551680, PMID:19545667, PMID:16251419 |
RGD:1582618, RGD:5129531, RGD:1582631 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mpo |
myeloperoxidase |
|
IEP ISO |
protein:increased activity:lung CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214, PMID:21470877 |
RGD:5130958 |
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
|
IEP |
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
|
IEP |
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:7692737 |
RGD:2298967 |
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO |
mRNA:increased expression:cerebrum (mouse) |
RGD |
PMID:12122050 |
RGD:6483850 |
NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:19635467 |
RGD:6480529 |
NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
IEP |
|
RGD |
PMID:23977093 |
RGD:7349380 |
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841
|
|
G |
Nes |
nestin |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:17569338 |
RGD:1642074 |
NCBI chr 2:187,343,109...187,352,972
Ensembl chr 2:187,344,056...187,352,969
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
IEP |
protein:increased expression:small intestine |
RGD |
PMID:20107953 |
RGD:5131440 |
NCBI chr19:19,342,061...19,389,366
Ensembl chr19:19,332,594...19,377,492
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IMP |
|
RGD |
PMID:17451676 |
RGD:1642142 |
NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) mRNA, protein:increased expression:liver |
CTD |
PMID:10383581 PMID:19673871 PMID:23061969 PMID:23075401, PMID:11592783, PMID:22019501, PMID:14599979 |
RGD:2325259, RGD:5509100, RGD:1580938 |
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21968084 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:18438942 |
RGD:2324666 |
NCBI chr 1:150,796,359...150,976,186
Ensembl chr 1:150,797,084...150,976,194
|
|
G |
Oga |
O-GlcNAcase |
|
IMP |
|
RGD |
PMID:16899550 |
RGD:2305957 |
NCBI chr 1:265,506,752...265,542,452
Ensembl chr 1:265,507,451...265,542,276
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
|
IEP |
mRNA, protein:decreased expression:hippocampus |
RGD |
PMID:17360495 |
RGD:2316611 |
NCBI chr 1:43,454,803...43,704,948
Ensembl chr 1:43,454,803...43,704,948
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased activity:serum |
RGD |
PMID:1499453 |
RGD:4144083 |
NCBI chr X:13,524,804...13,601,074
Ensembl chr X:13,524,607...13,601,069
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
|
IMP |
|
RGD |
PMID:18403049 |
RGD:2304111 |
NCBI chr 3:123,106,694...123,107,534
Ensembl chr 3:123,106,694...123,107,534
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat) |
CTD |
PMID:15696051 PMID:16798486, PMID:9390645, PMID:21850691 |
RGD:5510018, RGD:5510020 |
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
IEP ISO |
|
RGD |
PMID:19142196, PMID:19142196 |
RGD:6483555, RGD:6483555 |
NCBI chr 3:137,618,891...137,923,385
Ensembl chr 3:137,618,898...137,925,605
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
IMP |
|
RGD |
PMID:19474186 |
RGD:2314462 |
NCBI chr 2:226,899,604...227,044,916
Ensembl chr 2:226,900,619...227,041,576
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IMP IEP ISO |
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse) |
RGD |
PMID:12121711, PMID:21872880, PMID:22382321 |
RGD:2311660, RGD:6771206, RGD:6766379 |
NCBI chr10:94,850,971...94,913,202
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
IEP |
proetin:decreased dimerization:skeletal muscle (rat) |
RGD |
PMID:19100383 |
RGD:4108481 |
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
|
|
G |
Pklr |
pyruvate kinase L/R |
|
IEP |
|
RGD |
PMID:17013507 |
RGD:1625588 |
NCBI chr 2:188,449,158...188,458,034
Ensembl chr 2:188,449,210...188,459,592
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12967936 |
|
NCBI chr 5:157,282,650...157,285,295
Ensembl chr 5:157,282,669...157,285,328
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
IDA |
protein:increased activity:alveolar macrophage |
RGD |
PMID:1642455 |
RGD:1642456 |
NCBI chr13:67,062,252...67,206,688
Ensembl chr13:66,988,937...67,206,693
|
|
G |
Plat |
plasminogen activator, tissue type |
|
IDA ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9472885, PMID:15223382 |
RGD:2311674 |
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IEP ISO |
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic |
CTD |
PMID:15181847, PMID:19663807, PMID:18586014 |
RGD:6483808, RGD:6483830 |
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:18606671 |
RGD:6483829 |
NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
|
|
G |
Pld2 |
phospholipase D2 |
|
IEP |
protein:increased expression:hippocampus CA1, hippocampus granule cell layer mRNA:decreased expression:brainstem, cerebellum |
RGD |
PMID:17393174, PMID:17024567 |
RGD:2299901, RGD:2299902 |
NCBI chr10:57,161,921...57,181,148
Ensembl chr10:57,163,174...57,179,730
|
|
G |
Pnmt |
phenylethanolamine-N-methyltransferase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr10:86,340,893...86,342,501
Ensembl chr10:86,340,940...86,342,858
|
|
G |
Polb |
DNA polymerase beta |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr16:74,237,001...74,260,272
Ensembl chr16:74,237,001...74,260,271
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
IDA ISO |
liver ischemia/reperfusion injury CTD Direct Evidence: therapeutic |
CTD |
PMID:19151258, PMID:21305343 |
RGD:5509942 |
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12468449 PMID:24011919 PMID:24433871 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
IDA |
|
RGD |
PMID:14762344 |
RGD:1580702 |
NCBI chr 2:241,909,332...242,186,861
Ensembl chr 2:241,909,832...242,184,854
|
|
G |
Ppp3cb |
protein phosphatase 3 catalytic subunit beta |
|
ISO |
|
RGD |
PMID:14615291 |
RGD:1580705 |
NCBI chr15:4,209,702...4,236,895
Ensembl chr15:4,209,703...4,236,895
|
|
G |
Prdx6 |
peroxiredoxin 6 |
|
ISO |
|
RGD |
PMID:16766642 |
RGD:1580710 |
NCBI chr13:79,077,567...79,088,113
Ensembl chr13:79,077,033...79,088,127
|
|
G |
Prkca |
protein kinase C, alpha |
|
IMP |
|
RGD |
PMID:17905752 |
RGD:2292474 |
NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
|
|
G |
Prss1 |
serine protease 1 |
|
IEP |
|
RGD |
PMID:11062314 |
RGD:1599961 |
NCBI chr 4:70,776,046...70,779,249
Ensembl chr 4:70,776,046...70,779,249
|
|
G |
Ptafr |
platelet-activating factor receptor |
treatment |
ISO IMP |
|
RGD |
PMID:12812996, PMID:11139461 |
RGD:1581279, RGD:10043168 |
NCBI chr 5:150,746,284...150,775,675
Ensembl chr 5:150,754,021...150,775,672
|
|
G |
Pten |
phosphatase and tensin homolog |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19038262, PMID:17239858 |
RGD:2292538 |
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
|
|
G |
Ptges |
prostaglandin E synthase |
|
IEP ISO |
|
RGD |
PMID:12431630, PMID:16864802 |
RGD:2300116, RGD:2300094 |
NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10594344, PMID:16385084 |
RGD:5688223 |
NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IEP ISO IMP IDA |
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16386242 PMID:18258783 PMID:19673871, PMID:21394482, PMID:21944479, PMID:16247333 |
RGD:5135045, RGD:5508180, RGD:1580660 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
IEP |
protein:increased tyrosine phosphorylation:kidney |
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
|
|
G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
IDA |
protein:increased phosphorylation:hippocampus |
RGD |
PMID:15970382 |
RGD:1642621 |
NCBI chr15:42,827,306...42,947,796
Ensembl chr15:42,827,310...42,947,656
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
IEP ISO |
protein:increased expression:nucleus, liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20302854 PMID:23743330, PMID:18621400 |
RGD:2298777 |
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
S100b |
S100 calcium binding protein B |
|
IEP |
|
RGD |
PMID:18840784 |
RGD:5508834 |
NCBI chr20:13,130,633...13,142,856
Ensembl chr20:13,130,636...13,142,856
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
ISO |
|
RGD |
PMID:16403835 |
RGD:1580913 |
NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
|
|
G |
Scfd1 |
sec1 family domain containing 1 |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:9195952 |
RGD:633771 |
NCBI chr 6:72,124,408...72,202,703
Ensembl chr 6:72,124,417...72,202,713
|
|
G |
Sele |
selectin E |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17112405 PMID:23743330, PMID:19489247 |
RGD:2313598 |
NCBI chr13:82,355,234...82,365,323
Ensembl chr13:82,355,471...82,365,341
|
|
G |
Sell |
selectin L |
|
IEP |
|
RGD |
PMID:19489247 |
RGD:2313598 |
NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
|
|
G |
Selp |
selectin P |
|
IEP ISO |
|
RGD |
PMID:18521901, PMID:21701413 |
RGD:2312314, RGD:6218990 |
NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628
|
|
G |
Serpine2 |
serpin family E member 2 |
|
IEP |
|
RGD |
PMID:8261109 |
RGD:2317936 |
NCBI chr 9:85,560,852...85,629,410
Ensembl chr 9:85,560,863...85,626,094
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:23991040 |
RGD:8661644 |
NCBI chr 3:72,161,230...72,171,109
Ensembl chr 3:72,161,189...72,171,078
|
|
G |
Sftpc |
surfactant protein C |
|
IDA |
mRNA:decreased expression:lung |
RGD |
PMID:20560845 |
RGD:4144062 |
NCBI chr15:52,211,538...52,214,480
Ensembl chr15:52,211,544...52,214,616
|
|
G |
Si |
sucrase-isomaltase |
|
IEP |
|
RGD |
PMID:9724271 |
RGD:1625550 |
NCBI chr 2:170,220,794...170,301,348
Ensembl chr 2:170,221,245...170,301,348
|
|
G |
Sirt7 |
sirtuin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28675767 |
|
NCBI chr10:109,796,046...109,802,821
Ensembl chr10:109,796,020...109,802,739
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856
|
|
G |
Slc30a4 |
solute carrier family 30 member 4 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:18289514 |
RGD:2299950 |
NCBI chr 3:114,805,919...114,828,154
Ensembl chr 3:114,805,922...114,828,154
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
IEP |
protein:decreased expression:renal proximal tubule |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr17:9,747,766...9,762,739
Ensembl chr17:9,747,752...9,762,813
|
|
G |
Slc6a11 |
solute carrier family 6 member 11 |
|
IEP |
|
RGD |
PMID:13678673 |
RGD:1299345 |
NCBI chr 4:146,106,386...146,223,228
Ensembl chr 4:146,106,386...146,223,228
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
|
IEP |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 6:4,244,076...4,564,262
Ensembl chr 6:4,258,991...4,520,604
|
|
G |
Slc8a2 |
solute carrier family 8 member A2 |
|
IEP |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 1:78,029,555...78,054,042
Ensembl chr 1:78,025,995...78,060,111
|
|
G |
Slc8a3 |
solute carrier family 8 member A3 |
|
IEP |
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 6:104,889,500...105,099,408
Ensembl chr 6:104,891,376...105,097,054
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
|
IMP ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19027022, PMID:20337040 |
RGD:6771332 |
NCBI chr 5:151,573,122...151,626,360
Ensembl chr 5:151,573,092...151,627,316
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:16858290 |
RGD:2303111 |
NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768
|
|
G |
Slk |
STE20-like kinase |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:12965890 |
RGD:2304069 |
NCBI chr 1:267,359,761...267,415,735
Ensembl chr 1:267,359,830...267,412,810
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8215636 |
|
NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25780291 |
|
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IDA |
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Socs4 |
suppressor of cytokine signaling 4 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr15:24,056,383...24,070,868
Ensembl chr15:24,056,383...24,070,857
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330, PMID:15364863 |
RGD:1580834 |
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:8215636 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330, PMID:15612529, PMID:15087276 |
RGD:1582141, RGD:1581259 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sod3 |
superoxide dismutase 3 |
|
ISO |
|
RGD |
PMID:15778274 |
RGD:1581264 |
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:20548025 |
RGD:6903275 |
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
IEP |
protein:increased phosphorylation:hippocampus CA1 (rat) |
RGD |
PMID:20197063 |
RGD:2325012 |
NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
IDA IEP |
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney |
RGD |
PMID:15262323, PMID:17670769 |
RGD:1600103, RGD:2291900 |
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr 7:2,691,064...2,707,530
Ensembl chr 7:2,691,369...2,707,741
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:88,686,207...88,712,313
Ensembl chr10:88,686,207...88,754,829
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
|
|
G |
Stc1 |
stanniocalcin 1 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr15:50,891,137...50,901,791
Ensembl chr15:50,891,127...50,903,162
|
|
G |
Stc2 |
stanniocalcin 2 |
|
IEP |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
|
IEP ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25922074, PMID:16908442 |
RGD:2302564 |
NCBI chr14:22,070,861...22,089,264
Ensembl chr14:22,072,024...22,089,248
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
IDA |
associated with Cholestasis, Extrahepatic |
RGD |
PMID:15000260, PMID:8680115 |
RGD:1601451, RGD:1601475 |
NCBI chr 4:66,624,181...66,846,745
Ensembl chr 4:66,670,618...66,846,805
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16968891 |
|
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
IDA |
|
RGD |
PMID:22266265 |
RGD:6767573 |
NCBI chr20:18,594,057...18,606,106
Ensembl chr20:18,594,037...18,606,151
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
IEP |
|
RGD |
PMID:15613744 |
RGD:1579926 |
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
protein:increased expression:medulla oblongata (human) |
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:19342415 |
RGD:5131887 |
NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr 8:48,382,121...48,387,271
Ensembl chr 8:48,382,121...48,386,935
|
|
G |
Ticam1 |
toll-like receptor adaptor molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 |
|
NCBI chr 9:10,780,185...10,790,280
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
IEP |
protein:decreased expression:brain |
RGD |
PMID:17551674 |
RGD:2290424 |
NCBI chr 7:23,543,125...23,594,170
Ensembl chr 7:23,544,215...23,594,133
|
|
G |
Tjp1 |
tight junction protein 1 |
|
IEP |
protein:decreased expression:brain, endothelial cell |
RGD |
PMID:19374856, PMID:19929946 |
RGD:2325135, RGD:2325127 |
NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IEP ISO |
mRNA, protein:increased expression:kidney CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291, PMID:15912106 |
RGD:2312727 |
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:21355876 |
RGD:5128693 |
NCBI chr16:50,016,466...50,031,011
Ensembl chr16:50,016,857...50,031,214
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
IEP ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25780291 PMID:27064547, PMID:19473433, PMID:17126102 |
RGD:2312503, RGD:4144169 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:18005084 |
RGD:2291961 |
NCBI chr 7:141,039,433...141,070,269
Ensembl chr 7:141,034,982...141,069,989
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP |
|
RGD |
PMID:17109621 |
RGD:1624182 |
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
|
|
G |
Tp53 |
tumor protein p53 |
|
IEP |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:17661174 |
RGD:2290568 |
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
treatment |
IDA |
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 8:6,811,543...6,917,534
Ensembl chr 8:6,811,543...6,917,535
|
|
G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
IEP |
mRNA,protein:increased expression:hippocampus |
RGD |
PMID:18395621 |
RGD:5684390 |
NCBI chr 3:119,258,189...119,347,084
Ensembl chr 3:119,259,467...119,330,345
|
|
G |
Txn1 |
thioredoxin 1 |
|
IEP |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
|
|
G |
Txn2 |
thioredoxin 2 |
|
IEP |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 7:119,144,350...119,158,173
Ensembl chr 7:119,144,351...119,158,201
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
IEP |
mRNA:decreased expression:cerebral cortex mRNA:decreased expression:spinal cord |
RGD |
PMID:19128823, PMID:19409971 |
RGD:5685030, RGD:5685028 |
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
|
IEP |
mRNA:decreased expression:cerebral cortex |
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr11:86,667,994...86,716,063
Ensembl chr11:86,667,997...86,716,254
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:18813897 |
RGD:2313108 |
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
IEP |
|
RGD |
PMID:18704465 |
RGD:2315487 |
NCBI chr16:40,440,371...40,555,178
Ensembl chr16:40,440,207...40,555,576
|
|
G |
Vegfd |
vascular endothelial growth factor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16526316 |
|
NCBI chr X:31,816,480...31,852,239
Ensembl chr X:31,816,436...31,851,715
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23075401 |
|
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:21693218 |
RGD:5685379 |
NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582
|
|
G |
Wnt3a |
Wnt family member 3A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23875703 |
|
NCBI chr10:45,598,898...45,643,151
Ensembl chr10:45,598,912...45,638,035
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12910483, PMID:23403765 |
RGD:7247700 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
|
|
G |
Zfp354a |
zinc finger protein 354A |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:8382778 |
RGD:1300202 |
NCBI chr10:36,586,495...36,600,172
Ensembl chr10:36,589,181...36,600,469
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
IEP |
|
RGD |
PMID:9916935 |
RGD:11341701 |
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
ISO |
|
RGD |
PMID:19213942 |
RGD:9854642 |
NCBI chr 8:4,441,010...4,666,754
Ensembl chr 8:4,440,876...4,669,014
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
IEP |
|
RGD |
PMID:22217518, PMID:23769041 |
RGD:7245568, RGD:8695995 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
C3 |
complement C3 |
treatment |
IDA |
|
RGD |
PMID:25122638 |
RGD:11040803 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA |
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IDA |
liver |
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:12095034 |
RGD:11049508 |
NCBI chr16:81,824,610...81,834,923
Ensembl chr16:81,824,111...81,834,945
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IEP |
|
RGD |
PMID:22217518 |
RGD:7245568 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
IDA |
|
RGD |
PMID:23985719 |
RGD:10041002 |
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IMP |
|
RGD |
PMID:24598936 |
RGD:10450586 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Aco1 |
aconitase 1 |
|
IEP |
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chr 5:56,425,076...56,481,218
Ensembl chr 5:56,425,024...56,481,218
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:24370342 |
RGD:11035281 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
|
RGD |
PMID:17298994 |
RGD:7241819 |
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Clu |
clusterin |
treatment |
IEP |
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
|
RGD |
PMID:22845765 |
RGD:7241226 |
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
treatment |
IDA |
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
IEP |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA:increased expression:kidney: |
RGD |
PMID:15785371, PMID:11889420 |
RGD:10449491, RGD:11080974 |
NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
IEP |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IEP |
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
protein:increased secretion:T lymphocyte (human) |
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
protein:increased expression:kidney: |
RGD |
PMID:16221712, PMID:18192922 |
RGD:13208600, RGD:13208601 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:22305384 |
RGD:10395369 |
NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
|
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
IEP |
mRNA,protein:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
|
|
G |
Kitlg |
KIT ligand |
|
IEP |
mRNA:decreased expression:stomach: |
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Agt |
angiotensinogen |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
IEP |
|
RGD |
PMID:24232000 |
RGD:13792678 |
NCBI chr 7:12,426,807...12,432,120
Ensembl chr 7:12,426,809...12,432,130
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:small intestine |
RGD |
PMID:18475188 |
RGD:2307016 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Cd14 |
CD14 molecule |
|
IEP |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
|
|
G |
Cldn1 |
claudin 1 |
|
IEP |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
|
|
G |
Cldn3 |
claudin 3 |
|
IEP |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr12:21,831,341...21,832,813
Ensembl chr12:21,831,342...21,832,813
|
|
G |
Cldn5 |
claudin 5 |
|
IEP |
protein:decreased expression:colon: |
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr11:86,356,292...86,357,718
Ensembl chr11:86,356,294...86,357,718
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:increased expression:intestine: |
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:9117128 |
RGD:11039476 |
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
human protein in a rat model |
RGD |
PMID:22920553 |
RGD:11041662 |
NCBI chr16:81,824,610...81,834,923
Ensembl chr16:81,824,111...81,834,945
|
|
G |
Faslg |
Fas ligand |
treatment |
IEP |
|
RGD |
PMID:29170412 |
RGD:13792603 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
|
RGD |
PMID:22093738 |
RGD:10402181 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP |
|
RGD |
PMID:19362701 |
RGD:10766423 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hp |
haptoglobin |
treatment |
IEP |
|
RGD |
PMID:11922743 |
RGD:11041790 |
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
|
RGD |
PMID:12095141 |
RGD:11522715 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA |
|
RGD |
PMID:11959089 |
RGD:11062110 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Jak2 |
Janus kinase 2 |
|
IMP |
|
RGD |
PMID:22777122 |
RGD:10403072 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
IEP |
protein:increased expression:heart, kidney, liver, lung |
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
|
|
G |
Mbl2 |
mannose binding lectin 2 |
severity |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:19477015 |
RGD:12910933 |
NCBI chr 1:248,435,069...248,442,669
Ensembl chr 1:248,723,397...248,729,962
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:Peyer's patch |
RGD |
PMID:30206757 |
RGD:21409753 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir21 |
microRNA 21 |
|
IEP |
|
RGD |
PMID:30309483 |
RGD:41410822 |
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IDA |
|
RGD |
PMID:16610051 |
RGD:7777112 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:28382390 |
RGD:13440093 |
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:23331901 |
RGD:15042883 |
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
treatment |
IMP |
|
RGD |
PMID:15791006 |
RGD:13514040 |
NCBI chr16:8,350,168...8,457,999
Ensembl chr16:8,350,326...8,457,996
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
ISO |
mRNA:increased expression:jejunum (human) |
RGD |
PMID:20965186 |
RGD:9999150 |
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:15187522 |
RGD:11250409 |
NCBI chr18:24,918,402...24,928,822
Ensembl chr18:24,918,398...24,929,091
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
IEP |
|
RGD |
PMID:21046505 |
RGD:11035258 |
NCBI chr13:78,806,107...78,820,375
Ensembl chr13:78,805,347...78,833,192
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IDA |
protein:increased activity:plasma (rat) |
RGD |
PMID:12717359 |
RGD:11081012 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Vwf |
von Willebrand factor |
|
IEP |
protein:increased expression:plasma: |
RGD |
PMID:10365842 |
RGD:11080742 |
NCBI chr 4:158,085,059...158,219,525
Ensembl chr 4:158,088,505...158,219,523
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:23010742 |
RGD:13209016 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IMP |
|
RGD |
PMID:21680852 |
RGD:6893484 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chr X:32,050,734...32,095,860
Ensembl chr X:32,049,931...32,096,016
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
treatment |
IEP |
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
|
|
G |
Adam2 |
ADAM metallopeptidase domain 2 |
|
IEP |
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chr15:42,708,536...42,751,281
Ensembl chr15:42,708,387...42,751,330
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
IEP |
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
ISO |
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adm |
adrenomedullin |
treatment |
IEP ISO |
protein:increased expression:serum: |
RGD |
PMID:20538296, PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Anxa1 |
annexin A1 |
treatment |
IDA |
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
IEP |
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
|
|
G |
Apoa1 |
apolipoprotein A1 |
treatment |
ISO |
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:18221257, PMID:29285062 |
RGD:2293026, RGD:13792599 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
|
|
G |
Becn1 |
beclin 1 |
treatment |
IEP |
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
IEP |
mRNA, protein:increased expression:kidney |
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282
|
|
G |
C3 |
complement C3 |
treatment |
IEP |
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
|
IMP |
|
RGD |
PMID:19194162 |
RGD:7204479 |
NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp7 |
caspase 7 |
|
IEP |
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
treatment |
ISO |
|
RGD |
PMID:22160777 |
RGD:7247742 |
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO IDA |
mRNA, protein:increased expression:kidney, lung, serum |
RGD |
PMID:20396927, PMID:18650485 |
RGD:4891433, RGD:11526113 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
mRNA,protein:increased expression:kidney |
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IMP |
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cfb |
complement factor B |
|
ISO |
|
RGD |
PMID:16467447, PMID:12538716 |
RGD:7242709, RGD:7242734 |
NCBI chr20:4,536,206...4,542,073
Ensembl chr20:4,536,203...4,561,066 Ensembl chr20:4,536,203...4,561,066
|
|
G |
Cfh |
complement factor H |
treatment |
IEP ISO |
protein:decreased expression:serum: |
RGD |
PMID:20538296, PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
ISO |
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chr10:5,212,621...5,260,641
Ensembl chr10:5,213,350...5,260,608
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:23143303, PMID:19196448 |
RGD:7257565, RGD:7257570 |
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
|
RGD |
PMID:22189844, PMID:9407517 |
RGD:7204675, RGD:7204727 |
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20038794 |
RGD:7257679 |
NCBI chr 9:81,427,275...81,435,065
Ensembl chr 9:81,427,730...81,434,102
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
treatment |
IMP |
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:increased expression:kidney: |
RGD |
PMID:18480747, PMID:18480747 |
RGD:9587836, RGD:9587836 |
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
|
|
G |
Dhfr |
dihydrofolate reductase |
|
IEP |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
|
|
G |
Drd3 |
dopamine receptor D3 |
treatment |
IDA |
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chr11:61,819,102...61,883,223
Ensembl chr11:61,822,077...61,874,327
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
|
IEP |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
|
IEP |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr 6:75,050,329...75,075,795
Ensembl chr 6:75,050,329...75,075,795
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
IMP |
|
RGD |
PMID:16980042 |
RGD:10450580 |
NCBI chr 7:12,638,320...12,640,168
Ensembl chr 7:12,638,322...12,640,232
|
|
G |
Eng |
endoglin |
|
IEP ISO |
mRNA, protein:increased expression:kidney (rat) |
RGD |
PMID:16751653, PMID:16751653 |
RGD:7248779, RGD:7248779 |
NCBI chr 3:11,679,530...11,717,486
Ensembl chr 3:11,679,530...11,717,485
|
|
G |
Ep300 |
E1A binding protein p300 |
|
IEP |
protein:altered localization:kidney (rat) |
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:19961832, PMID:25581532 |
RGD:10401077, RGD:11041698 |
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IEP |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Faslg |
Fas ligand |
treatment |
IEP |
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fcgr1a |
Fc fragment of IgG receptor Ia |
treatment |
ISO |
|
RGD |
PMID:22402584 |
RGD:9685699 |
NCBI chr 2:198,430,536...198,439,453
Ensembl chr 2:198,430,530...198,458,041
|
|
G |
Fga |
fibrinogen alpha chain |
|
IEP |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fgb |
fibrinogen beta chain |
treatment |
IEP ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:21685370, PMID:21685370 |
RGD:7175292, RGD:7175292 |
NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178
|
|
G |
Fgg |
fibrinogen gamma chain |
|
IEP |
mRNA,protein:increased expression:kidney |
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fn1 |
fibronectin 1 |
|
IEP |
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
IEP ISO |
protein:increased expression:kidney: |
RGD |
PMID:20332418, PMID:20332418 |
RGD:9685723, RGD:9685723 |
NCBI chr10:14,059,347...14,061,703
Ensembl chr10:14,059,347...14,061,703
|
|
G |
Glo1 |
glyoxalase 1 |
|
IMP |
|
RGD |
PMID:19211689 |
RGD:7242566 |
NCBI chr20:9,273,589...9,291,608
Ensembl chr20:9,273,594...9,291,610
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IEP |
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Has1 |
hyaluronan synthase 1 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 1:59,720,612...59,732,409
Ensembl chr 1:59,720,612...59,732,409
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 7:96,438,046...96,464,049
Ensembl chr 7:96,438,046...96,464,049
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
IEP ISO |
protein:increased expression:urine: |
RGD |
PMID:23552495, PMID:23019274, PMID:23085062 |
RGD:7244372, RGD:7245495, RGD:7245489 |
NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment severity |
IDA IMP |
|
RGD |
PMID:17519789, PMID:22432008 |
RGD:1626334, RGD:9068883 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IMP |
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
IEP |
protein:increased expression:kidney (rat) |
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chr 7:117,538,523...117,565,478
Ensembl chr 7:117,538,523...117,565,478
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
IEP |
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Hyal1 |
hyaluronidase 1 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 8:116,332,834...116,337,522
Ensembl chr 8:116,332,796...116,335,435
|
|
G |
Hyal2 |
hyaluronidase 2 |
|
IEP |
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 8:116,324,062...116,328,978
Ensembl chr 8:116,324,040...116,328,978
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
mRNA: increased expression: kidney: 3 and 5 days post ischemia |
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
IMP |
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA ISO |
|
RGD |
PMID:24079335, PMID:28664613 |
RGD:7364864, RGD:14975137 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il18 |
interleukin 18 |
treatment |
IMP |
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
|
RGD |
PMID:20030532 |
RGD:7175501 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human protein mouse model treated with human protein |
RGD |
PMID:18363573, PMID:9555664, PMID:16849996 |
RGD:6907101, RGD:6909149, RGD:6907359 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
ISO IMP |
Associated with renal transplant patients |
RGD |
PMID:20504838, PMID:11007822 |
RGD:6907049, RGD:6907073 |
NCBI chr20:11,777,773...11,815,647
Ensembl chr20:11,777,783...11,815,647
|
|
G |
Kcnj11 |
potassium inwardly-rectifying channel, subfamily J, member 11 |
|
IEP |
protein:decreased expression:kidney |
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chr 1:102,103,093...102,107,134
Ensembl chr 1:102,103,094...102,106,127
|
|
G |
Kl |
Klotho |
treatment |
IEP ISO |
mRNA,protein:decreased expression:renal tubule: |
RGD |
PMID:16204278, PMID:16204278 |
RGD:10403064, RGD:10403064 |
NCBI chr12:942,974...987,206
Ensembl chr12:943,006...987,551
|
|
G |
Lcn2 |
lipocalin 2 |
|
IEP ISO |
protein:increased expression:urine: |
RGD |
PMID:23364806, PMID:23085062 |
RGD:7245469, RGD:7245489 |
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Lep |
leptin |
resistance |
IDA |
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lgals3 |
galectin 3 |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
treatment |
ISO IEP |
|
RGD |
PMID:20075199, PMID:26412257 |
RGD:11561916, RGD:11561958 |
NCBI chr 3:150,801,289...150,802,935
Ensembl chr 3:150,801,289...150,802,935
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
treatment |
IMP |
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chr 1:15,412,603...15,613,752
Ensembl chr 1:15,412,603...15,613,746
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
IEP |
protein:decreased expression:kidney outer medulla |
RGD |
PMID:18790174 |
RGD:5687322 |
NCBI chr19:56,215,420...56,219,987
|
|
G |
Mir381 |
microRNA 381 |
|
IEP |
RNA:decreased expression:kidney |
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr 6:133,876,615...133,876,675
Ensembl chr 6:133,876,586...133,876,693
|
|
G |
Mpo |
myeloperoxidase |
|
IEP ISO |
protein:increased activity:kidney |
RGD |
PMID:22950848, PMID:18055546 |
RGD:6909167, RGD:7174699 |
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Muc1 |
mucin 1, cell surface associated |
treatment |
IDA |
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IEP |
mRNA:increased expression:kidney (rat) |
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
IEP ISO |
|
RGD |
PMID:24096033, PMID:22160772 |
RGD:13801197, RGD:13801199 |
NCBI chr 1:264,298,671...264,303,712
Ensembl chr 1:264,298,669...264,303,762
|
|
G |
Nes |
nestin |
|
IEP |
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chr 2:187,343,109...187,352,972
Ensembl chr 2:187,344,056...187,352,969
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:29291552 |
RGD:13504682 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chr 5:164,808,407...164,809,716
Ensembl chr 5:164,808,323...164,809,705
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
severity |
ISO |
mRNA:increased expression:kidney |
RGD |
PMID:22343121, PMID:22343121 |
RGD:14700869, RGD:14700869 |
NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
IEP |
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Pax2 |
paired box 2 |
|
IEP |
mRNA, protein:increased expression:kidney |
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chr 1:264,493,579...264,585,073
Ensembl chr 1:264,504,591...264,583,329
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA,protein:increased expression:tubule, S3 segment: |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
IEP |
mRNA:increased expression:kidney |
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IMP IEP |
mRNA:increased expression:kidney |
RGD |
PMID:12819032, PMID:10550325 |
RGD:1580850, RGD:8554477 |
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
|
IEP |
protein:increased expression:kidney (rat) |
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chr14:6,602,004...6,645,257
Ensembl chr14:6,602,004...6,645,257
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
IDA |
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
|
|
G |
Rnls |
renalase, FAD-dependent amine oxidase |
|
ISO |
mRNA,protein:decreased expression:kidney,plasma: |
RGD |
PMID:23393318, PMID:23393318 |
RGD:7327166, RGD:7327166 |
NCBI chr 1:251,828,285...252,101,963
Ensembl chr 1:251,828,290...252,100,759
|
|
G |
Serpina1 |
serpin family A member 1 |
treatment |
ISO |
|
RGD |
PMID:28235038 |
RGD:14695051 |
NCBI chr 6:127,610,241...127,632,265
Ensembl chr 6:127,610,243...127,632,265
|
|
G |
Serpinc1 |
serpin family C member 1 |
severity |
IMP |
|
RGD |
PMID:26108065, PMID:26108065 |
RGD:11354006, RGD:11354006 |
NCBI chr13:78,806,107...78,820,375
Ensembl chr13:78,805,347...78,833,192
|
|
G |
Serpinc1em2Mcwi |
serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:26108065 |
RGD:11354006 |
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chr 4:718,538...727,691
Ensembl chr 4:718,538...727,691
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
IEP |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr 1:48,273,639...48,300,645
Ensembl chr 1:48,273,611...48,300,655
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
IEP |
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
|
IEP |
protein:decreased expression:renal proximal tubule, brush border membrane (rat) |
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr17:9,747,766...9,762,739
Ensembl chr17:9,747,752...9,762,813
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
IEP |
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
severity |
ISO |
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chr 3:71,852,738...71,902,127
Ensembl chr 3:71,852,744...71,893,618
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment severity |
IDA ISO |
|
RGD |
PMID:23239000, PMID:11801667, PMID:20130923, PMID:22750071, PMID:23023072 |
RGD:7207892, RGD:7241087, RGD:7240552, RGD:7207896, RGD:7207894 |
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
IDA ISO |
|
RGD |
PMID:23239000, PMID:11801667, PMID:20130923 |
RGD:7207892, RGD:7241087, RGD:7240552 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:19925291 |
RGD:2315112 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Vwf |
von Willebrand factor |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chr 4:158,085,059...158,219,525
Ensembl chr 4:158,088,505...158,219,523
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IMP |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:22995295, PMID:20616412 |
RGD:7247637, RGD:7247695 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
IDA |
|
RGD |
PMID:23762489 |
RGD:8695935 |
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adm |
adrenomedullin |
treatment |
IEP ISO |
mRNA,protein:increased expression:liver,plasma: |
RGD |
PMID:19212187, PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:21431875 |
RGD:10402078 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
treatment |
ISO IEP |
protein:altered expression:liver (mouse) protein:altered expression:liver (rat) |
RGD |
PMID:30671488, PMID:29589772 |
RGD:15036807, RGD:14975297 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IEP |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552, PMID:22847887 |
RGD:10053673, RGD:10053710 |
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22647552, PMID:21092002, PMID:22847887 |
RGD:10053673, RGD:5134995, RGD:10053710 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IDA IEP |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887, PMID:21092002 |
RGD:10053710, RGD:5134995 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
treatment |
IEP |
associated with Non-alcoholic Fatty Liver Disease |
RGD |
PMID:22847887 |
RGD:10053710 |
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
C3 |
complement C3 |
treatment |
IEP |
|
RGD |
PMID:19854450 |
RGD:11040888 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Casp12 |
caspase 12 |
treatment |
IEP |
|
RGD |
PMID:29428101 |
RGD:13782166 |
NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP ISO |
|
RGD |
PMID:23423194, PMID:15300206 |
RGD:8661760, RGD:14695087 |
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:23364428 |
RGD:13782358 |
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment severity |
IEP ISO |
mRNA, protein:increased expression:liver, serum (rat) |
RGD |
PMID:9500701, PMID:10630515, PMID:27229110 |
RGD:8549627, RGD:14995929, RGD:14995460 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment severity |
ISO |
|
RGD |
PMID:28623253, PMID:28623253 |
RGD:14995305, RGD:14995305 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
severity |
ISO |
|
RGD |
PMID:27229110 |
RGD:14995460 |
|
|
G |
Cd14 |
CD14 molecule |
|
IDA |
|
RGD |
PMID:22564590 |
RGD:7183676 |
NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IMP |
|
RGD |
PMID:14741776 |
RGD:8547795 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cfh |
complement factor H |
treatment |
IEP ISO |
mRNA,protein:decreased expression:liver,plasma: |
RGD |
PMID:19212187, PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
treatment |
IDA |
|
RGD |
PMID:21092002 |
RGD:5134995 |
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:18041715 |
RGD:27095942 |
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
IEP |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Elane |
elastase, neutrophil expressed |
|
IMP |
|
RGD |
PMID:10588515 |
RGD:10450560 |
NCBI chr 7:12,638,320...12,640,168
Ensembl chr 7:12,638,322...12,640,232
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
protein:increased phosphorylation:liver: |
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr 8:22,969,737...22,974,468
Ensembl chr 8:22,969,745...22,974,321
|
|
G |
F3 |
coagulation factor III, tissue factor |
treatment |
IMP |
|
RGD |
PMID:11750579 |
RGD:11341708 |
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IMP IEP |
protein:increased expression:liver |
RGD |
PMID:17235585, PMID:18561025, PMID:16222447 |
RGD:2290283, RGD:14700680, RGD:1600351 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Faslg |
Fas ligand |
treatment |
IMP |
|
RGD |
PMID:18561025 |
RGD:14700680 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fga |
fibrinogen alpha chain |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:23503399 |
RGD:9685021 |
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fn1 |
fibronectin 1 |
|
IDA |
|
RGD |
PMID:12651615 |
RGD:7205470 |
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
IDA |
associated with nonalcoholic fatty liver disease |
RGD |
PMID:28807209 |
RGD:13792730 |
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
IEP |
mRNA:decreased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IEP |
|
RGD |
PMID:23792534 |
RGD:8693718 |
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IMP IEP |
protein:increased oxidation:liver mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm |
RGD |
PMID:24578610, PMID:22514737, PMID:21431875 |
RGD:10402068, RGD:10402175, RGD:10402078 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP |
|
RGD |
PMID:20446775 |
RGD:10755725 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hp |
haptoglobin |
treatment |
IEP |
|
RGD |
PMID:17187421, PMID:21699906 |
RGD:1626366, RGD:11041815 |
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IMP IEP |
associated with Intestinal Reperfusion Injury;protein:increased expression:liver |
RGD |
PMID:7884306, PMID:8780571 |
RGD:11520784, RGD:14402044 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:28938192 |
RGD:14985248 |
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
IDA |
|
RGD |
PMID:22381173 |
RGD:12791280 |
NCBI chr X:156,254,187...156,280,046
Ensembl chr X:156,257,173...156,270,748
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA |
|
RGD |
PMID:21911118 |
RGD:7364839 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il18 |
interleukin 18 |
treatment |
IEP ISO |
|
RGD |
PMID:25919765, PMID:14999688 |
RGD:14696667, RGD:14696668 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
IEP |
mRNA,protein:increased expression:liver |
RGD |
PMID:25919765 |
RGD:14696667 |
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
IEP IDA |
mRNA:increased expression:lung protein:increased expression:serum |
RGD |
PMID:19595018, PMID:9840148, PMID:19283466 |
RGD:2314952, RGD:11059517, RGD:6907377 |
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
associated with Cholestasis |
RGD |
PMID:21468628 |
RGD:7175318 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO IMP |
rat model treated with human protein |
RGD |
PMID:9000676, PMID:12451245 |
RGD:6909138, RGD:8551710 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA |
|
RGD |
PMID:24752458 |
RGD:11062134 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
IDA |
|
RGD |
PMID:22288937 |
RGD:10403073 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:12134092 |
RGD:9685192 |
NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
IEP |
protein:increased activity:liver: |
RGD |
PMID:11679968 |
RGD:10412680 |
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Mfn2 |
mitofusin 2 |
treatment |
IEP |
mRNA, protein:decreased expression:liver (rat) |
RGD |
PMID:27363631, PMID:24898700 |
RGD:12910833, RGD:13204829 |
NCBI chr 5:164,684,244...164,715,414
Ensembl chr 5:164,684,509...164,714,145
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:28640790 |
RGD:21079442 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir21 |
microRNA 21 |
|
IEP |
RNA:increased expression:liver |
RGD |
PMID:29187695 |
RGD:41410824 |
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:liver RNA:increased expression:serum,liver |
RGD |
PMID:19104939, PMID:28646120 |
RGD:13831297, RGD:21408574 |
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
|
|
G |
Mir34a |
microRNA 34a |
|
IEP |
miRNA:increased expression:liver |
RGD |
PMID:28963950 |
RGD:14695005 |
NCBI chr 5:167,092,491...167,092,592
Ensembl chr 5:167,092,491...167,092,592
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr19:10,079,881...10,101,380
Ensembl chr19:10,079,765...10,101,451
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IEP |
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver |
RGD |
PMID:17255325 |
RGD:8547976 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
IEP |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
|
|
G |
Muc3 |
mucin 3, intestinal |
|
IEP |
mRNA, protein:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr12:22,535,663...22,584,775
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
IEP |
mRNA:decreased expression:bile duct |
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr11:71,242,973...71,285,217
Ensembl chr11:71,243,334...71,284,939
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
treatment |
IEP |
|
RGD |
PMID:22288937, PMID:31952110 |
RGD:10403073, RGD:21201304 |
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:28966130 |
RGD:13450941 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:12605111, PMID:18507760 |
RGD:11100021, RGD:11100046 |
NCBI chr18:24,918,402...24,928,822
Ensembl chr18:24,918,398...24,929,091
|
|
G |
Serpinc1 |
serpin family C member 1 |
treatment |
IEP ISO |
|
RGD |
PMID:24726586, PMID:8589354 |
RGD:10450597, RGD:11038771 |
NCBI chr13:78,806,107...78,820,375
Ensembl chr13:78,805,347...78,833,192
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IEP |
protein:increased activity:plasma (rat) |
RGD |
PMID:12353078 |
RGD:8547901 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:16367929 |
RGD:1580273 |
NCBI chr 3:72,161,230...72,171,109
Ensembl chr 3:72,161,189...72,171,078
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
|
RGD |
PMID:24557422 |
RGD:9497542 |
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
IEP |
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:16555330, PMID:11779401 |
RGD:8655889, RGD:1581095 |
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod3 |
superoxide dismutase 3 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:11779401 |
RGD:1581095 |
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19545665 |
RGD:11038676 |
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
|
ISO |
|
RGD |
PMID:9921794 |
RGD:11062061 |
NCBI chr 3:71,852,738...71,902,127
Ensembl chr 3:71,852,744...71,893,618
|
|
G |
Tlr2 |
toll-like receptor 2 |
treatment |
ISO IEP |
|
RGD |
PMID:16038046, PMID:25769561 |
RGD:15090805, RGD:15090809 |
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment severity |
IEP ISO |
mRNA:increased expression:liver protein:increased expression:membrane raft: |
RGD |
PMID:21431875, PMID:21693218, PMID:22797797, PMID:23395256, PMID:27064547 |
RGD:10402078, RGD:5685379, RGD:14697702, RGD:14697699, RGD:14697698 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IEP IMP |
protein:increased expression:serum (rat) |
RGD |
PMID:24726586, PMID:11592783, PMID:19357028, PMID:11129814, PMID:21125813, PMID:10454827, PMID:15457564, PMID:17164725 |
RGD:10450597, RGD:2325259, RGD:15039406, RGD:14995473, RGD:14995447, RGD:14985258, RGD:14985257, RGD:14696803 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP |
protein:increased localization:mitochondrion |
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
treatment |
IEP |
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr19:37,214,461...37,221,099
Ensembl chr19:37,214,471...37,216,572
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:22195248 |
RGD:7175309 |
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
IEP |
|
RGD |
PMID:26451003 |
RGD:15036791 |
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:24768926 |
RGD:13209011 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Egr1 |
early growth response 1 |
treatment |
IMP IEP |
|
RGD |
PMID:22878149, PMID:23232597 |
RGD:10395282, RGD:10395299 |
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
IMP |
|
RGD |
PMID:17888675 |
RGD:10450582 |
NCBI chr 7:12,638,320...12,640,168
Ensembl chr 7:12,638,322...12,640,232
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:21227458 |
RGD:10755577 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IEP |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA IEP |
protein:increased expression:lung (rat) |
RGD |
PMID:23142117, PMID:23122581 |
RGD:7183185, RGD:7204125 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il4 |
interleukin 4 |
treatment |
IDA |
|
RGD |
PMID:24365768 |
RGD:10402797 |
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased activity:lung |
RGD |
PMID:18694576 |
RGD:5129703 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment |
IEP |
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
IMP ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20815765, PMID:25382268 |
RGD:4892012, RGD:11533932 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
|
RGD |
PMID:21781312 |
RGD:6771212 |
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IDA IEP |
protein:increased expression:alveolar macrophage (rat) |
RGD |
PMID:21781312, PMID:16449942 |
RGD:6771212, RGD:11541083 |
NCBI chr10:94,850,971...94,913,202
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:19782612 |
RGD:11100035 |
NCBI chr18:24,918,402...24,928,822
Ensembl chr18:24,918,398...24,929,091
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO IDA |
protein:increased expression:plasma (human) |
RGD |
PMID:17846288, PMID:11606484 |
RGD:8547720, RGD:11080966 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Tlr4 |
toll-like receptor 4 |
treatment |
IEP |
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
|
IMP |
|
RGD |
PMID:17294835 |
RGD:4143397 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
|
ISO |
|
RGD |
PMID:18316485 |
RGD:2301903 |
NCBI chr 1:102,110,708...102,191,287
Ensembl chr 1:102,110,708...102,191,287
|
|
G |
Ada |
adenosine deaminase |
|
IDA |
protein:increased expression |
RGD |
PMID:16641873 |
RGD:1624305 |
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16155579 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10900253, PMID:17201736 |
RGD:5129149 |
NCBI chr 1:277,537,585...277,538,985
Ensembl chr 1:277,537,585...277,538,985
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
IDA |
|
RGD |
PMID:16269402 |
RGD:1598746 |
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IEP |
protein:increased expression:heart (rat) |
RGD |
PMID:16505177 |
RGD:1625342 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Agl |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
|
IMP |
|
RGD |
PMID:9281456 |
RGD:1598779 |
NCBI chr 2:219,788,234...219,843,189
Ensembl chr 2:219,788,234...219,842,986
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:2535056 PMID:19166939 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
IEP |
protein:increased expression:myocardium |
RGD |
PMID:21078800 |
RGD:5129194 |
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
IEP ISO |
protein:decreased expression:mitochondrion: |
RGD |
PMID:23685150, PMID:23685150 |
RGD:10053560, RGD:10053560 |
NCBI chr X:135,304,063...135,343,062
Ensembl chr X:135,304,066...135,343,087
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
IDA |
protein:increased phosphorylation:heart left ventricle |
RGD |
PMID:20217242 |
RGD:5509104 |
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
IDA |
|
RGD |
PMID:16418318 |
RGD:2313347 |
NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9572063 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
IDA |
|
RGD |
PMID:23468836 |
RGD:7241598 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IMP |
|
RGD |
PMID:20011686 |
RGD:2317527 |
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
mRNA, protein:increased expression:myocardium (rat) |
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
|
|
G |
Ank1 |
ankyrin 1 |
|
IDA |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr16:73,681,422...73,912,605
Ensembl chr16:73,681,422...73,827,488
|
|
G |
Ank2 |
ankyrin 2 |
|
IDA |
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr 2:231,224,643...231,522,655
Ensembl chr 2:231,226,949...231,648,122
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
|
IEP |
protein:decreased expression:myocardium |
RGD |
PMID:19299913 |
RGD:5133278 |
NCBI chr 1:254,726,985...254,745,673
Ensembl chr 1:254,726,969...254,735,548
|
|
G |
Anxa1 |
annexin A1 |
treatment |
IEP ISO |
protein:increased expression:heart, leukocyte |
RGD |
PMID:11641252, PMID:22924634, PMID:22924634 |
RGD:2306910, RGD:7421655, RGD:7421655 |
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
IEP |
protein:altered localization:cytoplasm |
RGD |
PMID:17602955 |
RGD:2315672 |
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
IEP |
|
RGD |
PMID:29016703 |
RGD:13506827 |
NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
|
|
G |
Atf3 |
activating transcription factor 3 |
|
IEP |
|
RGD |
PMID:11485922 |
RGD:7327201 |
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29702141 |
|
NCBI chr 2:204,003,742...204,032,023
Ensembl chr 2:204,003,742...204,032,023
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
IMP |
|
RGD |
PMID:17630344 |
RGD:13782075 |
NCBI chr 1:197,855,912...197,875,038
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10734148, PMID:28637456 |
RGD:13782080 |
NCBI chr12:39,553,903...39,603,326
Ensembl chr12:39,553,903...39,603,326
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
IEP |
protein:decreased expression:myocardium (rat) |
RGD |
PMID:26109848, PMID:25305180 |
RGD:13792666, RGD:13792676 |
NCBI chr 7:12,426,807...12,432,120
Ensembl chr 7:12,426,809...12,432,130
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IEP IDA |
protein:increased expression, decreased serine phosphorylation:heart |
RGD |
PMID:15339931, PMID:23364609 |
RGD:2292700, RGD:10053674 |
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20026869, PMID:21223820, PMID:25547710 |
RGD:10054103, RGD:13782178 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP IDA |
|
RGD |
PMID:16289365, PMID:20821058, PMID:23364609 |
RGD:1599484, RGD:11561911, RGD:10053674 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
treatment |
IDA |
|
RGD |
PMID:12668130 |
RGD:11035287 |
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Becn1 |
beclin 1 |
treatment |
IDA ISO |
|
RGD |
PMID:20821058, PMID:20812860 |
RGD:11561911, RGD:11561944 |
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
|
|
G |
Bid |
BH3 interacting domain death agonist |
|
IDA IEP |
protein:increased cleavage:heart: |
RGD |
PMID:19940077, PMID:11934844 |
RGD:2317561, RGD:13782263 |
NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
|
|
G |
Blk |
BLK proto-oncogene, Src family tyrosine kinase |
|
IEP |
mRNA:increased expression:left ventricle (rat) |
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chr15:46,555,552...46,593,778
Ensembl chr15:46,555,188...46,593,653
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
treatment |
IMP |
|
RGD |
PMID:16645637 |
RGD:11561983 |
NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
|
IEP |
mRNA:increased expression:heart |
RGD |
PMID:12909328 |
RGD:2289075 |
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
C3 |
complement C3 |
|
IEP |
protein:increased expression:myocardium |
RGD |
PMID:11560858 |
RGD:1582136 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C5 |
complement C5 |
treatment |
IDA IMP |
|
RGD |
PMID:9631876, PMID:23067403 |
RGD:1600666, RGD:7411626 |
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631 |
|
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
|
|
G |
Casp12 |
caspase 12 |
treatment |
IEP ISO |
protein:increased activity:myocardium CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631, PMID:19406177, PMID:25547710 |
RGD:2311458, RGD:13782178 |
NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
|
|
G |
Casp3 |
caspase 3 |
treatment |
IMP IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631, PMID:18470603, PMID:29538428 |
RGD:2293314, RGD:13782276 |
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp7 |
caspase 7 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631, PMID:29538428 |
RGD:13782276 |
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp8 |
caspase 8 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte |
CTD |
PMID:14998631, PMID:11934844 |
RGD:13782263 |
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell |
CTD |
PMID:14998631, PMID:29538428, PMID:11934844 |
RGD:13782276, RGD:13782263 |
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Casr |
calcium-sensing receptor |
|
IEP |
protein:increased expression:ventricular myocardium (rat) |
RGD |
PMID:21766206 |
RGD:7205698 |
NCBI chr11:67,188,204...67,262,261
Ensembl chr11:67,188,630...67,258,771
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:12482022 |
RGD:5683872 |
NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
|
|
G |
Cat |
catalase |
|
IEP ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21600015, PMID:11510883 |
RGD:1581149 |
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cbl |
Cbl proto-oncogene |
severity |
ISO |
|
RGD |
PMID:24583314 |
RGD:11251947 |
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP ISO |
mRNA:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12087064, PMID:10908159 |
RGD:8549625 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
protein:decreased expression:monocyte: |
RGD |
PMID:15786508 |
RGD:4892017 |
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
treatment |
ISO IEP |
protein:decreased expression:blood, monocyte (human) |
RGD |
PMID:15786508, PMID:23456481 |
RGD:4892017, RGD:8552227 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:18466417 |
RGD:11341714 |
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
IMP |
|
RGD |
PMID:18771032 |
RGD:2316217 |
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
IMP |
|
RGD |
PMID:17950273 |
RGD:2316224 |
NCBI chr 5:154,242,010...154,268,126
Ensembl chr 5:154,260,062...154,268,126
|
|
G |
Crp |
C-reactive protein |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
protein:decreased expression:blood, monocyte |
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IMP |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IMP |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
|
IMP |
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
|
|
G |
Cybb |
cytochrome b-245 beta chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19207477 |
|
NCBI chr X:14,578,330...14,610,049
Ensembl chr X:14,578,264...14,612,547
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14998631 |
|
NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
|
IMP IEP |
|
RGD |
PMID:18586023, PMID:12193087 |
RGD:4892580, RGD:7244160 |
NCBI chr 5:156,215,469...156,318,652
Ensembl chr 5:156,215,417...156,318,671
|
|
G |
Edn1 |
endothelin 1 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15642760 PMID:16700825, PMID:18586023 |
RGD:4892580 |
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Ednra |
endothelin receptor type A |
|
IMP |
|
RGD |
PMID:18586023 |
RGD:4892580 |
NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703
|
|
G |
Ednrb |
endothelin receptor type B |
|
IMP |
|
RGD |
PMID:21048781 |
RGD:4892332 |
NCBI chr15:88,004,775...88,036,354
Ensembl chr15:88,006,977...88,036,354
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
susceptibility |
ISO |
|
RGD |
PMID:20185832 |
RGD:11251775 |
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19834332 |
|
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:18314151 |
RGD:4892299 |
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:18656630 |
RGD:5508820 |
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO IEP |
|
RGD |
PMID:26038570, PMID:26948086 |
RGD:11341801, RGD:13792504 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IDA |
|
RGD |
PMID:21316771 |
RGD:8686424 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:27129213 |
RGD:11574725 |
NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
|
|
G |
Gcg |
glucagon |
treatment |
ISO |
|
RGD |
PMID:24125539 |
RGD:10402369 |
NCBI chr 3:48,442,635...48,451,650
Ensembl chr 3:48,442,635...48,451,650
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17445419 |
|
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Glrx |
glutaredoxin |
|
IEP |
mRNA:decreased expression:heart: |
RGD |
PMID:18163565 |
RGD:2306160 |
NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
treatment severity susceptibility |
IMP ISO IDA |
associated with Diabetes Mellitus, Experimental protein:increased expression:heart, mitochondrion (mouse) associated with Hypertension |
RGD |
PMID:27865836, PMID:23467820, PMID:24170934, PMID:27296507, PMID:27601479 |
RGD:13513990, RGD:13792779, RGD:13792704, RGD:13513995, RGD:13513993 |
NCBI chr 1:219,536,220...219,544,329
Ensembl chr 1:219,536,220...219,544,328
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
IDA IEP |
|
RGD |
PMID:20217242, PMID:26918336, PMID:29978610 |
RGD:5509104, RGD:13792772, RGD:13792725 |
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP |
|
RGD |
PMID:24769323 |
RGD:10401892 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IDA |
|
RGD |
PMID:23108649 |
RGD:8693739 |
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
IEP ISO IDA |
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism protein:increased expression:myocardium |
CTD |
PMID:18549825 PMID:22050707, PMID:12189448, PMID:20170615, PMID:19727523 |
RGD:1626327, RGD:9068872, RGD:5147885 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IEP ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21113057, PMID:23531454, PMID:19540007 |
RGD:10402066, RGD:10402170 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IDA ISO IEP |
|
RGD |
PMID:12709584, PMID:23921302, PMID:22179023 |
RGD:1598392, RGD:10755585, RGD:10755573 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hrh2 |
histamine receptor H 2 |
susceptibility |
ISO |
|
RGD |
PMID:23467745 |
RGD:9685524 |
NCBI chr17:10,912,959...10,931,389
Ensembl chr17:10,921,507...10,952,441
|
|
G |
Hrh3 |
histamine receptor H3 |
|
IDA |
|
RGD |
PMID:15076218 |
RGD:1626433 |
NCBI chr 3:175,474,310...175,479,395
Ensembl chr 3:175,473,078...175,479,395
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
|
ISO |
|
RGD |
PMID:22426029 |
RGD:10402789 |
NCBI chr 7:117,538,523...117,565,478
Ensembl chr 7:117,538,523...117,565,478
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
treatment |
IEP |
|
RGD |
PMID:24129401, PMID:25547710 |
RGD:11354962, RGD:13782178 |
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
|
ISO |
protein:increased expression:myocardium, cytosol (mouse) |
RGD |
PMID:15611365 |
RGD:5688376 |
NCBI chr 4:113,883,671...113,886,833
Ensembl chr 4:113,883,670...113,886,994
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP ISO |
protein:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12087064, PMID:20851484 |
RGD:4145348 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Il10 |
interleukin 10 |
treatment |
IEP IDA |
protein:increased expression:plasma |
RGD |
PMID:19275881, PMID:23840272 |
RGD:2311056, RGD:7365001 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il17a |
interleukin 17A |
treatment |
IMP |
|
RGD |
PMID:22030025 |
RGD:9068944 |
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il18 |
interleukin 18 |
|
ISO IDA |
|
RGD |
PMID:19164288, PMID:19805173 |
RGD:4889578, RGD:4889400 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il18bp |
interleukin 18 binding protein |
|
ISO |
mRNA:increased expression:heart |
RGD |
PMID:19164288, PMID:19805173 |
RGD:4889578, RGD:4889400 |
NCBI chr 1:167,091,521...167,095,727
Ensembl chr 1:167,091,522...167,093,560
|
|
G |
Il18rap |
interleukin 18 receptor accessory protein |
|
ISO |
|
RGD |
PMID:19164288 |
RGD:4889578 |
NCBI chr 9:47,225,543...47,255,805
Ensembl chr 9:47,225,585...47,258,503
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
ISO IEP |
|
RGD |
PMID:8576926, PMID:7622355 |
RGD:7794741, RGD:7794764 |
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP |
mRNA:increased expression:heart |
RGD |
PMID:17134725 |
RGD:1626628 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human protein |
RGD |
PMID:22649318 |
RGD:7174360 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA |
|
|